| 注册
首页|期刊导航|世界中西医结合杂志|益气化痰活血类中药干预2型糖尿病伴颈动脉病变的Meta分析

益气化痰活血类中药干预2型糖尿病伴颈动脉病变的Meta分析

肖瑶 潘欣渝 徐明君 曾贵兴 魏军平

世界中西医结合杂志2025,Vol.20Issue(1):16-27,12.
世界中西医结合杂志2025,Vol.20Issue(1):16-27,12.DOI:10.13935/j.cnki.sjzx.250103

益气化痰活血类中药干预2型糖尿病伴颈动脉病变的Meta分析

Meta-analysis of Type 2 Diabetes Mellitus with Carotid Artery Lesions Intervened by Qi-benefiting,Phlegm-resolving,and Blood-activating Chinese Medicines

肖瑶 1潘欣渝 2徐明君 1曾贵兴 2魏军平2

作者信息

  • 1. 北京中医药大学,北京 100029||中国中医科学院广安门医院,北京 100053
  • 2. 中国中医科学院广安门医院,北京 100053
  • 折叠

摘要

Abstract

Objective To systematically evaluate the efficacy and safety of qi-benefiting,phlegm-resolving,and blood-activating Chinese medicines in the treatment of type 2 diabetes mellitus(T2DM)complicated by carotid artery lesions.Methods Multiple databases including China National Knowledge Infrastructure(CNKI),Wanfang Data,VIP,China Biology Medicine disc(CBMdisc),PubMed,Web of Science,and The Cochrane Library were searched for random-ized controlled trials(RCTs)published up to September 18,2023,involving the use of qi-benefiting,phlegm-resolving,and blood-activating Chinese medicines in the treatment of T2DM with carotid artery lesions.Two reviewers independently conducted literature screening and data extraction,and the Cochrane Risk of Bias tool was used for quality assessment.Me-ta-analysis was performed using RevMan 5.4 software.Results A total of 27 studies involving 2 574 participants were included.The Meta-analysis showed that,compared to the control group,the combination of qi-benefiting,phlegm-re-solving,and blood-activating Chinese medicines with conventional Western medication had a significant advantage in im-proving the total effective rate[OR=2.69,95%CI(2.09,3.46)],reducing carotid intima-media thickness(CIMT)[MD=-0.15,95%CI(-0.20,-0.10)],plaque area[MD=-0.25,95%CI(-0.38,-0.12)],plaque score[MD=-0.39,95%CI(-0.56,-0.21)],improving insulin resistance[MD=-0.48,95%CI(-0.59,-0.37)],reducing glycated hemoglobin[MD=-0.45,95%CI(-0.70,-0.19)],lowering total cholesterol[MD=-0.43,95%CI(-0.66,-0.21)],lowering low-density lipoprotein cholesterol[MD=-0.32,95%CI(-0.43,-0.21)],reducing homocysteine[MD=-2.30,95%CI(-3.15,-1.44)],and lowering high-sensitivity C-reactive protein[MD=-1.67,95%CI(-2.38,-0.95)],with all differences being statistically significant(P<0.01).The safety of the com-bination treatment was similar to that of conventional Western treatment alone[MD=0.82,95%CI(0.43,1.55),P=0.53].Conclusion Qi-benefiting,phlegm-resolving,and blood-activating Chinese medicines can effectively treat T2DM with carotid artery lesions without increasing the risk of adverse reactions.However,due to the low quality of the in-cluded studies,further large-scale,multi-center,high-quality RCTs are needed to confirm these findings.

关键词

益气化痰活血/2型糖尿病/颈动脉硬化/临床疗效/安全性/Meta分析

Key words

Benefiting Qi,Resolving Phlegm,and Activating Blood/Type 2 Diabetes Mellitus/Carotid Atheroscle-rosis/Clinical Efficacy/Safety/Meta-analysis

分类

医药卫生

引用本文复制引用

肖瑶,潘欣渝,徐明君,曾贵兴,魏军平..益气化痰活血类中药干预2型糖尿病伴颈动脉病变的Meta分析[J].世界中西医结合杂志,2025,20(1):16-27,12.

基金项目

中央高水平中医医院临床研究和成果转化能力提升项目中医药临床循证研究专项(HLCMHPP2023084) (HLCMHPP2023084)

中央高水平中医院医院临床科研业务领军人才培育项目(CZ40905) (CZ40905)

中国中医科学院科技创新工程项目(CI2021A01617) (CI2021A01617)

中国中医科学院中医药循证能力建设项目(60104) (60104)

世界中西医结合杂志

1673-6613

访问量0
|
下载量0
段落导航相关论文